Sign up to save your podcasts
Or
Share Biotech Insights: MIT’s Robert Langer on Startups & mRNA Innovation
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Biotech Insights: MIT’s Robert Langer on Startups & mRNA Innovation
In this episode of Startuprad.io, host Joe Menninger sits down with Professor Robert S. Langer, a renowned biotechnologist from MIT. Professor Langer, co-founder of Moderna and holder of over 1,400 patents, shares his expertise on biotech startups, innovation, and the future of mRNA technology.
Explore the critical differences between biotech sectors in Europe and the US, the key factors for biotech startup success, and the importance of great science, intellectual property, and business acumen. Professor Langer also discusses the essential role of government and private sector partnerships in fostering biotech innovation.
Discover insights on:
Biotech landscapes in Europe vs. the US
Success factors for biotech startups
Future of mRNA technology
Government and private sector partnerships
Diversity in research and its benefits
Funding challenges for biotech startups
Advancements in drug delivery systems
Memorable Quotes:
"Great science and intellectual property are the cornerstones of biotech success."
"Diversity in research teams leads to innovative outcomes."
Enjoyed this episode? Leave a review and share it with your network! Subscribe to our podcast for more expert interviews and insights. Join our vibrant community of tech entrepreneurs and stay updated with the latest in biotech innovation.
Links:
Original Blog Post: https://www.startuprad.io/blog
Work with us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
#Biotech #Startup #Innovation #mRNA #RobertLanger #MIT #ModernMedicine #TechEntrepreneurship #Startupradio #Podcast
View all episodes
By [email protected]In this episode of Startuprad.io, host Joe Menninger sits down with Professor Robert S. Langer, a renowned biotechnologist from MIT. Professor Langer, co-founder of Moderna and holder of over 1,400 patents, shares his expertise on biotech startups, innovation, and the future of mRNA technology.
Explore the critical differences between biotech sectors in Europe and the US, the key factors for biotech startup success, and the importance of great science, intellectual property, and business acumen. Professor Langer also discusses the essential role of government and private sector partnerships in fostering biotech innovation.
Discover insights on:
Biotech landscapes in Europe vs. the US
Success factors for biotech startups
Future of mRNA technology
Government and private sector partnerships
Diversity in research and its benefits
Funding challenges for biotech startups
Advancements in drug delivery systems
Memorable Quotes:
"Great science and intellectual property are the cornerstones of biotech success."
"Diversity in research teams leads to innovative outcomes."
Enjoyed this episode? Leave a review and share it with your network! Subscribe to our podcast for more expert interviews and insights. Join our vibrant community of tech entrepreneurs and stay updated with the latest in biotech innovation.
Links:
Original Blog Post: https://www.startuprad.io/blog
Work with us: https://www.startuprad.io/become-a-partner
Subscribe: https://linktr.ee/startupradio
#Biotech #Startup #Innovation #mRNA #RobertLanger #MIT #ModernMedicine #TechEntrepreneurship #Startupradio #Podcast
More shows like 📰 Startup & Tech News from Germany, Austria, and Switzerland
View all
🎙️ Startuprad.io™ – Europe’s Voice on Startups, VC, Innovation & Growth
229 Listeners
💳 FinTech Germany – Startups and Venture Capital
1 Listeners
🔐 Security Sutra – Cybersecurity Startups and Venture Capital
0 Listeners
Blockchain Germany - Startups and Venture Capital
0 Listeners
🧪 Deep Tech Germany – Startups and Venture Capital
0 Listeners
Tech Startups Germany - Startups and Venture Capital
0 Listeners
Starting Y
0 Listeners
European Startup Pulse
0 Listeners
👩🚀 Women Who Rock GSA – A Female Entrepreneurship Podcast
0 Listeners